September 2009
BioWorld Insight;9/14/2009, Vol. 17 Issue 37, p7
The article presents the pharmaceutical companies in the U.S. with their medicines and indications which received the approval from the Food and Drug Administration (FDA) in August 2009 which include Kowa Pharmaceuticals America Inc., Eurand NV, Janssen Pharmaceutica NV and King Pharmaceuticals Inc.


Related Articles

  • LATELINES.  // Drug Topics;11/6/2000, Vol. 144 Issue 21, p5 

    Presents news briefs on the pharmaceutical industry as of November 6, 2000. Decision of Janseen Pharmaceutica to discontinue the production of the drug Ergamisol; Approval of the drug Fosamax; Introduction of Women's Tylenol Menstrual Relief by McNeil Consumer Healthcare; Decision of the United...

  • BELGIUM: Europe's Pharma Brew House.  // Pharmaceutical Executive;Apr2013, Vol. 33 Issue 4, pS2 

    The article reports on the pharmaceutical industry of Belgium, which is a great contributor to the country's trade balance. Laurette Onkelinx, minister of Social Affairs and Public Health, says the Belgian pharmaceutical market is valued at approximately 6.1 billion U.S. dollars and the nation's...

  • Pharma: Other News To Note.  // BioWorld Today;4/20/2012, Vol. 23 Issue 77, p10 

    This section offers news briefs related to the pharmaceutical industry, including the plan of Baxter International Inc. to build a manufacturing facility in Covington, Georgia, Janssen Pharmaceutica NV's launched a division called Janssen Therapeutics EMEA, and Sanofi SA's collaboration with the...

  • Collaborations Between Biotech And Pharmaceutical Companies: Apr. 1 - May 27, 2011.  // BioWorld Insight;5/30/2011, Vol. 19 Issue 22, p7 

    A chart is presented that lists the collaborations between biotechnology and pharmaceutical companies in the U.S. from April 1, 2011 to May 27, 2011 including that of 4SC AG with Yakult Honsha Co. Ltd., Active Biotech AB with Ipsen SA, and Beatica AB with Janssen Pharmaceutica NV.

  • The importance of the laboratory to the pharmaceutical business. Hawkins, Juanita M. // Journal of Automated Methods & Management in Chemistry;Mar2000, Vol. 22 Issue 2, p47 

    Understanding the contributions that the laboratory can make in product/process development, process improvement, market surveil lance and general business is key to the pharmaceutical business today. Poor laboratory practice yields compliance issues, increased cost, increased cycle time and...

  • Brand Watch.  // Drug Store News;11/27/2000, Vol. 22 Issue 18, p13 

    Presents news updates on pharmaceutical industry in the United States as of November 27, 2000. Grant of the Food and Drug Administration for Aslera from Genelabs Technologies; Voluntary decision of Janssen Pharmaceutica to discontinue Ergamisol tablet manufacturing; Approval for the...

  • Johnson & Johnson appoints Fabregas to Janssen. Ruano, Lida Estela // Caribbean Business;4/1/1999, Vol. 27 Issue 12, p8 

    Discloses the promotion of Edgardo J. Fabregas to vice president of operations at Janssen Pharmaceutica Inc. Other management changes at the company.

  • Johnson & Johnson unit in legal settlement over Propulsid suit.  // PharmaWatch: CNS;March 2004, Vol. 3 Issue 3, p15 

    Reports on the settlement agreement reached by Johnson & Johnson's Janssen Pharmaceutica NV to settle a lawsuit stemming from its Propulsid drug targeting heatburn symptoms. Terms of the agreement; Financial terms of the settlement; Requirements for the settlement agreement.

  • Update.  // Medical Marketing & Media;Dec2004, Vol. 39 Issue 12, p15 

    The article presents information on various developments related to the pharmaceutical industry. Janssen Pharmaceutica NV has received several medication error reports involving its Alzheimer's drug Reminyl being confused with Aventis' diabetes therapy Amaryl. Based on the prescribing errors,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics